In 1937, a Turkish dermatologist, Hulusi Behcet, discovered the association of oral and genital ulcerations with hypopyon-uveitis. Americans pronounce is Bah-shetts; however it is French and should be pronounced Bah-Cheys. Since then, Behcet’s Disease was associated with vasculitis. The disease is recognized worldwide, but there are significant differences in the epidemiological, genetic and clinical characteristics of the disorder between ethnic groups and in different geographic locations. As there are no specific manifestations nor specific diagnostic tests, the term "Behcet’s Syndrome" is preferred by some, especially for patients from low-prevalence areas whose disease manifestations are generally less severe and possibly due to other underlying conditions (known as the trisomy of Behcet's which is EDS, POTS, and MCAD). The disease is associated with significant morbidity and mortality if not treated. Treatment is dependent on the site and severity of manifestations. In America, it is considered a faux pas to call BD Behcet's Syndrome because it took many years to have it classified as a disease. The medical community doesn't tend to take syndromes as seriously.